{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:09:29Z","timestamp":1787238569484,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00245453"],"award-info":[{"award-number":["RS-2023-00245453"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-024-00533-y","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T11:02:11Z","timestamp":1723719731000},"page":"631-648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Population Pharmacokinetics of Loxoprofen and its alcoholic metabolites in healthy Korean men"],"prefix":"10.1007","volume":"32","author":[{"given":"Ji-Hun","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Suk","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7515-0631","authenticated-orcid":false,"given":"Seung-Hyun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"533_CR1","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1016\/j.bmc.2011.04.050","volume":"19","author":"N Yamakawa","year":"2011","unstructured":"Yamakawa N, Suemasu S, Matoyama M, Tanaka K-I, Katsu T, Miyata K, Okamoto Y, Otsuka M, Mizushima T. Synthesis and biological evaluation of loxoprofen derivatives. Bioorg Med Chem. 2011;19:3299\u2013311. https:\/\/doi.org\/10.1016\/j.bmc.2011.04.050.","journal-title":"Bioorg Med Chem"},{"key":"533_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40261-016-0440-9","volume":"36","author":"SL Greig","year":"2016","unstructured":"Greig SL, Garnock-Jones KP. Loxoprofen: a review in pain and inflammation. Clin Drug Investig. 2016;36:771\u201381. https:\/\/doi.org\/10.1007\/s40261-016-0440-9.","journal-title":"Clin Drug Investig"},{"key":"533_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0006-2952(95)00124-I","volume":"50","author":"H Ohara","year":"1995","unstructured":"Ohara H, Miyabe Y, Deyashiki Y, Matsuura K, Kara A. Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver. Biochem Pharmacol. 1995;50:221\u20137. https:\/\/doi.org\/10.1016\/0006-2952(95)00124-I.","journal-title":"Biochem Pharmacol"},{"key":"533_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000211713","volume":"79","author":"T Arakawa","year":"2009","unstructured":"Arakawa T, Fujiwara Y, Sollano JD, Zhu Q, Kachintorn U, Rani AA, Hahm K-B, Takahashi S-I, Joh T, Kinoshita Y. A questionnaire-based survey on the prescription of non-steroidal anti-inflammatory drugs by physicians in East Asian countries in 2007. Digestion. 2009;79:177\u201385. https:\/\/doi.org\/10.1159\/000211713.","journal-title":"Digestion"},{"key":"533_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10067-014-2701-4","volume":"35","author":"R Mu","year":"2016","unstructured":"Mu R, Bao C-D, Chen Z-W, Zheng Y, Wang G-C, Zhao D-B, Hu S-X, Li Y-J, Shao Z-W, Zhang Z-Y. Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with knee osteoarthritis: a randomized controlled non-inferiority trial. Clin Rheumatol. 2016;35:165\u201373. https:\/\/doi.org\/10.1007\/s10067-014-2701-4.","journal-title":"Clin Rheumatol"},{"key":"533_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00776-015-0726-4","volume":"20","author":"H Sekiguchi","year":"2015","unstructured":"Sekiguchi H, Inoue G, Nakazawa T, Imura T, Saito W, Uchida K, Miyagi M, Takahira N, Takaso M. Loxoprofen sodium and celecoxib for postoperative pain in patients after spinal surgery: a randomized comparative study. J Orthop Sci. 2015;20:617\u201323. https:\/\/doi.org\/10.1007\/s00776-015-0726-4.","journal-title":"J Orthop Sci"},{"key":"533_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jos.2018.02.007","volume":"23","author":"K Miki","year":"2018","unstructured":"Miki K, Ikemoto T, Hayashi K, Arai Y-C, Sekiguchi M, Shi K, Ushida T. Randomized open-labbel non-inferiority trial of acetaminophen or loxoprofen for patients with acute low back pain. J Orthop Sci. 2018;23:483\u20137. https:\/\/doi.org\/10.1016\/j.jos.2018.02.007.","journal-title":"J Orthop Sci"},{"key":"533_CR8","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1097\/CM9.0000000000002797","volume":"136","author":"D Li","year":"2023","unstructured":"Li D, Cheng Y, Yuan P, Wu Z, Liu J, Kan J, Zhang K, Wang Z, Zhang H, Zhang G. Efficacy and safety of flurbiprofen cataplasms versus loxoprofen sodium cataplasms in knee osteoarthritis: a randomized controlled trial. Chin Med J. 2023;136:2187\u201394. https:\/\/doi.org\/10.1097\/CM9.0000000000002797.","journal-title":"Chin Med J"},{"key":"533_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3109\/14397595.2013.852857","volume":"24","author":"S Ohta","year":"2014","unstructured":"Ohta S, Komai O, Hanakawa H. Comparative study of the clinical efficacy of the selective cyclooxygenase-2 inhibitor celecoxib compared with loxoprofen in patients with frozen shoulder. Mod Rheumatol. 2014;24:144\u20139. https:\/\/doi.org\/10.3109\/14397595.2013.852857.","journal-title":"Mod Rheumatol"},{"key":"533_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/ph16020161","volume":"16","author":"J-H Jang","year":"2023","unstructured":"Jang J-H, Jeong S-H, Lee Y-B. Population pharmacokinetic modeling of zaltoprofen in healthy adults: exploring the dosage regimen. Pharmaceuticals. 2023;16:161. https:\/\/doi.org\/10.3390\/ph16020161.","journal-title":"Pharmaceuticals"},{"key":"533_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00210-023-02640-0","volume":"397","author":"S-H Jeong","year":"2024","unstructured":"Jeong S-H, Jang J-H, Lee Y-B. Modeling population pharmacokinetics of morniflumate in healthy Korean men: extending pharmacometrics analysis to niflumic acid, its major active metabolite. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2024;397:843\u201356. https:\/\/doi.org\/10.1007\/s00210-023-02640-0.","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"533_CR12","first-page":"587","volume":"32","author":"M Kashif","year":"2013","unstructured":"Kashif M, Rahman N-U, Idrees HA, Aslam I, Iqbal SM, Mustafa R. HPLC-UV detection method for quantification of loxoprofen in human plasma with liquid-liquid extraction technique: application in pharmacokinetic study. Lat Am J Pharm. 2013;32:587\u201392.","journal-title":"Lat Am J Pharm"},{"key":"533_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/cpdd.15","volume":"2","author":"SA Helmy","year":"2013","unstructured":"Helmy SA. Pharmacokinetics and bioequivalence evaluation of 2 loxoprofen tablets in healthy egyptian male volunteers. Clin Pharmacol Drug Dev. 2013;2:173\u20137. https:\/\/doi.org\/10.1002\/cpdd.15.","journal-title":"Clin Pharmacol Drug Dev"},{"key":"533_CR14","first-page":"2038","volume":"3","author":"P Loya","year":"2011","unstructured":"Loya P, Kshatriya AA, Saraf MN. Bioequivalence study of two brands of loxoprofen tablets in healthy volunteers. Int J PharmTech Res. 2011;3:2038\u201346.","journal-title":"Int J PharmTech Res"},{"key":"533_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4333\/KPS.2011.41.2.117","volume":"41","author":"H-A Kang","year":"2011","unstructured":"Kang H-A, Cho H-Y, Lee Y-B. Bioequivalence of hana loxoprofen sodium tablet to dongwha Loxonin\u00ae tablet (Loxoprofen Sodium 60 mg). J Pharm Investig. 2011;41:117\u201323. https:\/\/doi.org\/10.4333\/KPS.2011.41.2.117.","journal-title":"J Pharm Investig"},{"key":"533_CR16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/bmc.1175","volume":"23","author":"HW Lee","year":"2009","unstructured":"Lee HW, Ji HY, Sohn DH, Kim SM, Lee YB, Lee HS. Liquid chromatography\u2013tandem mass spectrometry method of loxoprofen in human plasma. Biomed Chromatogr. 2009;23:714\u20138. https:\/\/doi.org\/10.1002\/bmc.1175.","journal-title":"Biomed Chromatogr"},{"key":"533_CR17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1055\/s-0031-1296646","volume":"57","author":"OH Jhee","year":"2007","unstructured":"Jhee OH, Lee MH, Shaw LM, Lee SE, Park JH, Kang JS. Pharmacokinetics and bioequivalence study of two brands of loxoprofen tablets in healthy volunteers. Arzneimittelforschung. 2007;57:542\u20136. https:\/\/doi.org\/10.1055\/s-0031-1296646.","journal-title":"Arzneimittelforschung"},{"key":"533_CR18","first-page":"211","volume":"11","author":"L Hao","year":"2006","unstructured":"Hao L, Sun J-G, Wang G-J, Jiang X-L, Xie Y-Y, Li P. Rapid determination of loxoprofen in human plasma by HPLC-MS and its pharmacokinetics and bioequivalence study. Chin J Clin Pharmacol Ther. 2006;11:211.","journal-title":"Chin J Clin Pharmacol Ther"},{"key":"533_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jchromb.2006.02.058","volume":"835","author":"H-Y Cho","year":"2006","unstructured":"Cho H-Y, Park C-H, Lee Y-B. Direct and simultaneous analysis of loxoprofen and its diastereometric alcohol metabolites in human serum by on-line column switching liquid chromatography and its application to a pharmacokinetic study. J Chromatogr B. 2006;835:27\u201334. https:\/\/doi.org\/10.1016\/j.jchromb.2006.02.058.","journal-title":"J Chromatogr B"},{"key":"533_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/jps.10040","volume":"91","author":"I-W Kim","year":"2002","unstructured":"Kim I-W, Chung S-J, Shim C-K. Altered metabolism of orally administered loxoprofen in human subjects after an oral administration of loxoprofen for three consecutive days followed by a seven-day washout. J Pharm Sci. 2002;91:973\u20139. https:\/\/doi.org\/10.1002\/jps.10040.","journal-title":"J Pharm Sci"},{"key":"533_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0731-7085(00)00583-5","volume":"25","author":"K-S Choo","year":"2001","unstructured":"Choo K-S, Kim I-W, Jung J-K, Suh Y-G, Chung S-J, Lee M-H, Shim C-K. Simultaneous determination of loxoprofen and its diastereomeric alcohol metabolites in human plasma and urine by a simple HPLC-UV detection method. J Pharm Biomed Anal. 2001;25:639\u201350. https:\/\/doi.org\/10.1016\/S0731-7085(00)00583-5.","journal-title":"J Pharm Biomed Anal"},{"key":"533_CR22","first-page":"185","volume":"28","author":"I-W Kim","year":"1998","unstructured":"Kim I-W, Han T-G, Kim K-S, Chung S-J, Lee M-H, Shim C-K. Bioequivalence of loxipen tablet to loxonin tablet (sodium loxoprofen anhydride 60 mg). J Pharm Investig. 1998;28:185\u201391.","journal-title":"J Pharm Investig"},{"key":"533_CR23","first-page":"73","volume":"7","author":"S-J Kim","year":"1997","unstructured":"Kim S-J, Oh I-J, Shin S-C, Lee Y-B, Joh H-N, Suh S-P. Bioequivalence of loxoprofen tablets. Korean J Clin Pharm. 1997;7:73\u201380.","journal-title":"Korean J Clin Pharm"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-024-00533-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-024-00533-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-024-00533-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T12:08:27Z","timestamp":1731326907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-024-00533-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["533"],"URL":"https:\/\/doi.org\/10.1007\/s40199-024-00533-y","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical studies were conducted in accordance with the Rules of Good Clinical Practice and the revised Declaration of Helsinki for Biomedical Research with Human Subjects. All subjects had no prior history of hypersensitivity or related reactions to steroid drugs and were physically normal. In addition, healthy adults aged 19\u201355\u00a0years have no history of digestive, liver, kidney, cardiovascular, central nervous system, endocrine, or blood diseases in the past, and have not been taking any other drugs. All subjects underwent a physical examination, clinical screening, complete blood count, urinalysis, and blood chemistry analyzes prior to participation in this clinical study to confirm their physical health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All subjects provided written informed consent prior to their participation in bioequivalence and pharmacokinetic studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All data were anonymized and participants were informed that the results of this study may be subject to publication and presentation in meetings.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest relevant to this study to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/ Competing interests"}}]}}